New 13D20
New 13G51
Stated intents1
The week of 2025-11-17, 20 holders filed a new Schedule 13D and 51 a new Schedule 13G reporting 5% or more of a company, and 1 13D filing stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-11-20 | Ardagh Metal Packaging S.A. | Ardagh Group S.A. | 76.02% | SCHEDULE 13D |
| 2025-11-19 | Nature Wood Group Ltd | Wang Liying | 70.18% | SCHEDULE 13D |
| 2025-11-17 | Airwa Inc. | Hongyu Zhou | 55.8% | SCHEDULE 13D |
| 2025-11-20 | MapLight Therapeutics, Inc. | Catalyst4, Inc. | 45.1% | SCHEDULE 13D |
| 2025-11-17 | Smith Micro Software, Inc. | Smith William W Jr | 30% | SCHEDULE 13D |
| 2025-11-18 | Tailwind 2.0 Acquisition Corp. | Tailwind 2.0 Sponsor LLC | 25.49% | SCHEDULE 13D |
| 2025-11-17 | Miluna Acquisition Corp | MilunaC Technology Limited | 20.93% | SCHEDULE 13D |
| 2025-11-17 | Damora Therapeutics Inc | Fairmount Funds Management LLC | 19.99% | SCHEDULE 13D |
| 2025-11-19 | Pure Cycle Corporation | Maran Capital Management, LLC | 14.7% | SCHEDULE 13D |
| 2025-11-17 | Evommune, Inc. | RA Capital Management, L.P. | 11% | SCHEDULE 13D |
| 2025-11-18 | Carbon Revolution Public Limited Company | Mark T. Mitchell Revocable Living Trust U/A dated July 31, 1998, as amended | 9.8% | SCHEDULE 13D |
| 2025-11-20 | MAGNACHIP SEMICONDUCTOR Corp | Byreforge LLC | 8.5% | SCHEDULE 13D |
| 2025-11-17 | E.W. SCRIPPS Co | Sinclair, Inc. | 8.2% | SCHEDULE 13D |
| 2025-11-18 | Columbus Circle Capital Corp I | Glazer Capital, LLC | 7.7% | SCHEDULE 13D |
| 2025-11-21 | Powercompute, Inc. | Hyperscale Data, Inc. | 7.3% | SCHEDULE 13D |
| 2025-11-20 | Parkervision Inc | Titterton Lewis H jr | 7% | SCHEDULE 13D |
| 2025-11-17 | Unifirst Corp | River Road Asset Management, LLC | 6.1% | SCHEDULE 13D |
| 2025-11-18 | Jack In The Box Inc | GreenWood Investors LLC | 6.1% | SCHEDULE 13D |
| 2025-11-18 | Braemar Hotels & Resorts Inc. | Blackwells Capital LLC | 5.8% | SCHEDULE 13D |
| 2025-11-21 | 1stdibs.com, Inc. | John A. Catsimatidis Jr. | 5.1% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-11-21 | Polibeli Group Ltd | Xingyun International Company Limited | 98.26% | SCHEDULE 13G |
| 2025-11-20 | Fitness Champs Holdings Limited | Big Treasure Investments Limited | 51.22% | SCHEDULE 13G |
| 2025-11-18 | Netskope, Inc. | Sanjay Beri | 36.7% | SCHEDULE 13G |
| 2025-11-17 | GSR IV Acquisition Corp. | GSR IV Sponsor LLC | 26.7% | SCHEDULE 13G |
| 2025-11-21 | TCW Steel City Senior Lending BDC | Nationwide Life Insurance Co | 20.4% | SCHEDULE 13G |
| 2025-11-20 | Sunrise New Energy Co., Ltd. | Yong Rong (HK) Asset Management Ltd | 18.1% | SCHEDULE 13G |
| 2025-11-18 | Cypherpunk Technologies Inc. | Severns Sean Michael | 10.59% | SCHEDULE 13G |
| 2025-11-18 | enGene Holdings Inc. | Perceptive Advisors LLC | 9.99% | SCHEDULE 13G |
| 2025-11-20 | Surf Air Mobility Inc. | Park Lane Investments, LLC | 9.99% | SCHEDULE 13G |
| 2025-11-21 | Verastem, Inc. | Deep Track Capital, LP | 9.99% | SCHEDULE 13G |
| 2025-11-17 | Aprea Therapeutics, Inc. | Lytton Laurence W | 9.9% | SCHEDULE 13G |
| 2025-11-18 | Decoy Therapeutics Inc. | CVI Investments, Inc. | 9.9% | SCHEDULE 13G |
| 2025-11-18 | Figure Technology Solutions Inc | Matthew C. Bonner | 9.5% | SCHEDULE 13G |
| 2025-11-19 | enVVeno Medical Corp | Thomas A. Satterfield, Jr. | 9% | SCHEDULE 13G |
| 2025-11-18 | Vor Biopharma Inc. | Paradigm BioCapital Advisors LP | 8.6% | SCHEDULE 13G |
| 2025-11-18 | SuperX AI Technology Ltd | Mirae Asset Securities (HK) Ltd | 8.3% | SCHEDULE 13G |
| 2025-11-19 | Blueport Acquisition Ltd | Feis Equities LLC | 8.02% | SCHEDULE 13G |
| 2025-11-18 | NightFood Holdings, Inc. | Eagle Equities LLC | 7.96% | SCHEDULE 13G |
| 2025-11-19 | Claritev Corp | Arini Capital Management Limited | 7.64% | SCHEDULE 13G |
| 2025-11-17 | T Stamp Inc | Galloway Capital Partners, LLC | 7.56% | SCHEDULE 13G |
| 2025-11-18 | Klarna Group plc | Siemiatkowski Sebastian | 7.49% | SCHEDULE 13G |
| 2025-11-17 | Kyverna Therapeutics, Inc. | GordonMD Global Investments LP | 7% | SCHEDULE 13G |
| 2025-11-21 | TCW Steel City Senior Lending BDC | Nationwide Mutual Insurance Co | 6.8% | SCHEDULE 13G |
| 2025-11-18 | enGene Holdings Inc. | Deep Track Capital, LP | 6.69% | SCHEDULE 13G |
| 2025-11-20 | Surrozen, Inc. | Millennium Management LLC | 6.6% | SCHEDULE 13G |
| 2025-11-20 | Opendoor Technologies Inc. | D. E. Shaw & Co., L.P. | 6.4% | SCHEDULE 13G |
| 2025-11-18 | Keros Therapeutics, Inc. | ExodusPoint Capital Management, LP | 6.3% | SCHEDULE 13G |
| 2025-11-18 | Elite Express Holding Inc. | Hawkeyes Investment Ltd | 6.1% | SCHEDULE 13G |
| 2025-11-17 | Evommune, Inc. | Andera Partners | 6% | SCHEDULE 13G |
| 2025-11-20 | Seneca Bancorp, Inc. | Minerva Advisors LLC | 6% | SCHEDULE 13G |
| 2025-11-20 | Yorkville Acquisition Corp. | Decagon Asset Management LLP | 5.81% | SCHEDULE 13G |
| 2025-11-20 | Diginex Ltd | Nalimz Holdings Ltd | 5.7% | SCHEDULE 13G |
| 2025-11-17 | Cantor Equity Partners II Inc | RichRich Capital LLC | 5.63% | SCHEDULE 13G |
| 2025-11-18 | CleanCore Solutions, Inc. | MMCAP International Inc. SPC | 5.5% | SCHEDULE 13G |
| 2025-11-19 | Orchestra Biomed Holdings, Inc. | Dana Lorenzo | 5.5% | SCHEDULE 13G |
| 2025-11-19 | Crocs Inc | WIT Partners Advisory Pte. Ltd. | 5.5% | SCHEDULE 13G |
| 2025-11-21 | Acrivon Therapeutics, Inc. | Kenneth Griffin | 5.5% | SCHEDULE 13G |
| 2025-11-21 | Binah Capital Group, Inc. | Alta Partners LLC | 5.5% | SCHEDULE 13G |
| 2025-11-18 | Compass Minerals International, Inc. | M Partners Fund LP | 5.49% | SCHEDULE 13G |
| 2025-11-19 | Quanterix Corp | Telegraph Hill Partners III, L.P. | 5.4% | SCHEDULE 13G |
| 2025-11-17 | Cytek Biosciences, Inc. | Topline Capital Management, LLC | 5.3% | SCHEDULE 13G |
| 2025-11-21 | EchoStar Corporation | Darsana Capital Partners LP | 5.3% | SCHEDULE 13G |
| 2025-11-21 | Ondas Inc | Jane Street Group, LLC | 5.3% | SCHEDULE 13G |
| 2025-11-17 | Ascent Industries Co. | Pinnacle Family Office Investments, L.P., a Texas limited partnership 27-1405464 | 5.28% | SCHEDULE 13G |
| 2025-11-20 | Riot Platforms Inc | Jane Street Group, LLC | 5.2% | SCHEDULE 13G |
| 2025-11-17 | Amylyx Pharmaceuticals, Inc. | Commodore Capital LP | 5.1% | SCHEDULE 13G |
| 2025-11-19 | ICL Group Ltd. | Menora Mivtachim Holdings Ltd | 5.03% | SCHEDULE 13G |
| 2025-11-17 | OraSure Technologies, Inc. | Neil Gagnon | 5% | SCHEDULE 13G |
| 2025-11-17 | Empery Digital Inc. | Streeterville Capital LLC | 5% | SCHEDULE 13G |
| 2025-11-20 | Lexeo Therapeutics, Inc. | Paradigm BioCapital Advisors LP | 5% | SCHEDULE 13G |
| 2025-11-20 | United Parks & Resorts Inc. | Steven A. Tananbaum | 5% | SCHEDULE 13G |
Stated intent
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-11-21 | Carver Bancorp Inc | Mann Barry James intent stated | 8.5% | SCHEDULE 13D/A |
Download this data (CSV)72 rows, with sources
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.